Advanced or Metastatic NSCLC
2 competing products in clinical development for Advanced or Metastatic NSCLC.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Datopotamab deruxtecan + Durvalumab + Carboplatin + AZD2936 + MEDI5752 + AZD7789 | Daiichi Sankyo | Phase 1 | Active | 33 |
| Datopotamab deruxtecan + KEYTRUDA® + Carboplatin + Cisplatin | Daiichi Sankyo | Phase 1 | Active | 33 |